speb/financial-data huggingface dataset:
ACX.TO income_statement (annual, 2025-12-31) — Net Interest Income: -8270000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -2218000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -5684000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 4440000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -5684000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 4440000.00
ACX.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -8270000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2218000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2103000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -34000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 1393000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -6136000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Net PPE: 158163000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 158163000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -48622000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -12265000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 144598000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 144598000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 15794000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 15794000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 9718000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 9718000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 15794000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 15794000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 9718000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 9718000.00
ACX.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 69427000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 16163000.00
ACX.TO income_statement (annual, 2025-12-31) — Normalized Income: 24524400.00
ACX.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 6532600.00
ACX.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 91679000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 40453000.00
ACX.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 5807000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 1974000.00
ACX.TO income_statement (annual, 2025-12-31) — Operating Income: 26736000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Operating Income: 4402000.00
ACX.TO income_statement (annual, 2025-12-31) — Operating Revenue: 474928000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 109301000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 33138000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 33138000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 26697000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 26697000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 15472000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 15472000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 1242000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1242000.00
ACX.TO income_statement (annual, 2025-12-31) — Other Gand A: 19298000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Other Gand A: -25486000.00
ACX.TO income_statement (annual, 2025-12-31) — Other Income Expense: -10524000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -3996000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 62793000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 62793000.00
ACX.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 8270000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 2218000.00
ACX.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 4846000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 0.00
ACX.TO balance_sheet (annual, 2025-12-31) — Other Properties: 292077000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 292077000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 14789000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 14789000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Payables: 95711000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Payables: 95711000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 95711000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 95711000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 6320000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 6320000.00
ACX.TO income_statement (annual, 2025-12-31) — Pretax Income: 7942000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -1812000.00
ACX.TO cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 731000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -4115000.00
ACX.TO cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -477000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -64000.00
ACX.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -49382000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -12465000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Receivables: 96263000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 96263000.00
ACX.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 336357000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 79826000.00
ACX.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 42691000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 11761000.00
ACX.TO income_statement (annual, 2025-12-31) — Rent And Landing Fees: 0.00
ACX.TO income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 43809000.00
ACX.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -19340000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -6534000.00
ACX.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -10151000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -3463000.00
ACX.TO income_statement (annual, 2025-12-31) — Research And Development: 4980000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Research And Development: 1276000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 24222000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 24222000.00
ACX.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 40020000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 37522000.00
ACX.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 760000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 200000.00
ACX.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 59318000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 12036000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Share Issued: 33138000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 33138000.00
ACX.TO income_statement (annual, 2025-12-31) — Special Income Charges: -4221000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -1941000.00
ACX.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2330000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: -559000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 248773000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 248773000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 144598000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 144598000.00
ACX.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1578600.00
ACX.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -599400.00
ACX.TO income_statement (annual, 2025-12-31) — Tax Provision: -7637000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Tax Provision: -4948000.00
ACX.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
ACX.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
ACX.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 3066000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 3066000.00
ACX.TO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -271000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: 108000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Total Assets: 462382000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 462382000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 309705000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 309705000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Total Debt: 108180000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 108180000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 248773000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 248773000.00
ACX.TO income_statement (annual, 2025-12-31) — Total Expenses: 448192000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 104899000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 213609000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 213609000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 278132000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 278132000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 86152000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 86152000.00
ACX.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 23542000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 3488000.00
ACX.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -10524000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -3996000.00
ACX.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -10524000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3996000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Treasury Stock: 229000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 229000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Working Capital: 56793000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 56793000.00
ACX.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 21970000.00
ACX.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 144463000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 118096000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 119777000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -152319000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 17908000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 2980000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 2980000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 945000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 34942000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.14
ACX.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 34650000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 11319000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -10625000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 21351000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 200475000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 16453000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 16453000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 16453000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 7436000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -25708000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -245000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -21409000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -18517000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 200475000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 264913000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 3965000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1618000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 114444000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 211351000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 5251000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 30914000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 36739000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 155155000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 1744000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 1744000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 9869000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 12849000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 3157000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 12849000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 3157000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 38568000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.13
ACX.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 4845000.00
ACX.TO income_statement (quarterly, 2026-03-31) — EBIT: 9251000.00
ACX.TO income_statement (quarterly, 2026-03-31) — EBITDA: 22100000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 320000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 16453000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 7436000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -10870000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 219000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 763000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 2302000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 16513000.00
ACX.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 17403000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 43986000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 112041000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 337043000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 30019000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 982000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 2662000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2662000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -2130000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 49830000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 372071000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -25708000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 3965000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 9080000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 16100000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 76244000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 92344000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1895000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -17235000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 2347000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 90705000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -2333000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Net Income: 4845000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 4845000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 4845000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 4845000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 4845000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 4845000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 4845000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -63000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -2662000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 7185000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1895000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2662000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 34000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 1481000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 184724000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -9891000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 9080000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 152872000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 13172000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 8876000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 13172000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 8876000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 20898000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 3961149.64
ACX.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -245000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2114000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Operating Income: 8049000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 144463000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 34905000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 30914000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 16513000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 1242000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 16906000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 1202000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 68055000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2662000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 325724000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 15041000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Payables: 118416000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 118416000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 7207000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 6589000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -17235000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -63000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -10562000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 137861000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 104752000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 12849000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1895000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1618000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Research And Development: 1410000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 881000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 29004000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 497000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 671000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 17403000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 34905000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 9080000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: -1100000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 159000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 264913000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 152872000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 318149.64
ACX.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 1744000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
ACX.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 3043000.00
ACX.TO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: 74000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 521288000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 341157000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 129083000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 264913000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 136414000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 256375000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 309937000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 101220000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 7830000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 320000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1202000.00
ACX.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1202000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 229000.00
ACX.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 56196000.00
ACXP balance_sheet (annual, 2021-12-31) — Gains Losses Not Affecting Retained Earnings: -26548309.00
ACXP cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
ACXP cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
ACXP cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
ACXP cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
ACXP cash_flow (annual, 2021-12-31) — Operating Gains Losses: 850262.00
ACXP balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: -26548309.00
ACXP income_statement (annual, 2021-12-31) — Other Income Expense: 66503.00
ACXP cash_flow (annual, 2021-12-31) — Other Non Cash Items: 1587741.00
ACXP income_statement (annual, 2021-12-31) — Other Special Charges: -66503.00
ACXP cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: 916765.00
ACXP income_statement (annual, 2021-12-31) — Special Income Charges: 66503.00
ACXP income_statement (annual, 2021-12-31) — Total Unusual Items: 66503.00
ACXP income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 66503.00
ACXP income_statement (annual, 2022-12-31) — +Operating Expense: 12092776.00
ACXP income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
ACXP balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 45944478.00
ACXP income_statement (annual, 2022-12-31) — Basic Average Shares: 540820.00
ACXP income_statement (annual, 2022-12-31) — Basic EPS: -22.40
ACXP cash_flow (annual, 2022-12-31) — Beginning Cash Position: 12958846.00
ACXP balance_sheet (annual, 2022-12-31) — Capital Stock: 11628.00
ACXP balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 9111751.00
ACXP balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 9111751.00
ACXP balance_sheet (annual, 2022-12-31) — Cash Financial: 9111751.00
ACXP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 3695195.00
ACXP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -7542290.00
ACXP cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1217776.00
ACXP cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 30349.00
ACXP cash_flow (annual, 2022-12-31) — Change In Receivables: 0.00
ACXP cash_flow (annual, 2022-12-31) — Change In Working Capital: 1248125.00
ACXP cash_flow (annual, 2022-12-31) — Changes In Cash: -3847095.00
ACXP balance_sheet (annual, 2022-12-31) — Common Stock: 11628.00
ACXP balance_sheet (annual, 2022-12-31) — Common Stock Equity: 7315021.00
ACXP cash_flow (annual, 2022-12-31) — Common Stock Issuance: 3695182.00
ACXP balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1489251.00
ACXP balance_sheet (annual, 2022-12-31) — Current Assets: 9376706.00
ACXP balance_sheet (annual, 2022-12-31) — Current Liabilities: 2061685.00
ACXP income_statement (annual, 2022-12-31) — Diluted Average Shares: 540820.00
ACXP income_statement (annual, 2022-12-31) — Diluted EPS: -22.40
ACXP income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -12092776.00
ACXP income_statement (annual, 2022-12-31) — EBIT: -12092776.00
ACXP income_statement (annual, 2022-12-31) — EBITDA: -12092776.00
ACXP cash_flow (annual, 2022-12-31) — End Cash Position: 9111751.00
ACXP cash_flow (annual, 2022-12-31) — Financing Cash Flow: 3695195.00
ACXP cash_flow (annual, 2022-12-31) — Free Cash Flow: -7542290.00
ACXP balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -38641085.00
ACXP income_statement (annual, 2022-12-31) — General And Administrative Expense: 7338505.00
ACXP balance_sheet (annual, 2022-12-31) — Invested Capital: 7315021.00
ACXP cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 3695182.00
ACXP cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 3695182.00
ACXP income_statement (annual, 2022-12-31) — Net Income: -12092776.00
ACXP income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -12092776.00
ACXP income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -12092776.00
ACXP income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -12092776.00
ACXP income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -12092776.00
ACXP cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -12092776.00
ACXP income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -12092776.00
ACXP balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 7315021.00
ACXP income_statement (annual, 2022-12-31) — Normalized EBITDA: -12092776.00
ACXP income_statement (annual, 2022-12-31) — Normalized Income: -12092776.00
ACXP cash_flow (annual, 2022-12-31) — Operating Cash Flow: -7542290.00
ACXP income_statement (annual, 2022-12-31) — Operating Income: -12092776.00
ACXP income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
ACXP balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 581380.00
ACXP balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -38641085.00
ACXP income_statement (annual, 2022-12-31) — Other Gand A: 7338505.00
ACXP cash_flow (annual, 2022-12-31) — Other Non Cash Items: 430680.00
ACXP balance_sheet (annual, 2022-12-31) — Other Payable: 29539.00
ACXP balance_sheet (annual, 2022-12-31) — Payables: 29539.00
ACXP balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1518790.00
ACXP cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 0.00
ACXP balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 542895.00
ACXP balance_sheet (annual, 2022-12-31) — Prepaid Assets: 264955.00
ACXP income_statement (annual, 2022-12-31) — Pretax Income: -12092776.00
ACXP cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 13.00
ACXP balance_sheet (annual, 2022-12-31) — Receivables: 0.00
ACXP income_statement (annual, 2022-12-31) — Research And Development: 4754271.00
ACXP balance_sheet (annual, 2022-12-31) — Retained Earnings: -38641085.00
ACXP income_statement (annual, 2022-12-31) — Selling General And Administration: 7338505.00
ACXP balance_sheet (annual, 2022-12-31) — Share Issued: 581380.00
ACXP income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
ACXP cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3302361.00
ACXP balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7315021.00
ACXP balance_sheet (annual, 2022-12-31) — Tangible Book Value: 7315021.00
ACXP income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ACXP income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
ACXP balance_sheet (annual, 2022-12-31) — Total Assets: 9376706.00
ACXP balance_sheet (annual, 2022-12-31) — Total Capitalization: 7315021.00
ACXP balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 7315021.00
ACXP income_statement (annual, 2022-12-31) — Total Expenses: 12092776.00
ACXP balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2061685.00
ACXP balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 0.00
ACXP balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ACXP balance_sheet (annual, 2022-12-31) — Total Partnership Capital: -38641085.00
ACXP income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
ACXP income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ACXP balance_sheet (annual, 2022-12-31) — Working Capital: 7315021.00
ACXP income_statement (annual, 2023-12-31) — +Operating Expense: 14577768.00
ACXP income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
ACXP balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 57871070.00
ACXP income_statement (annual, 2023-12-31) — Basic Average Shares: 633578.00
ACXP income_statement (annual, 2023-12-31) — Basic EPS: -23.00
ACXP cash_flow (annual, 2023-12-31) — Beginning Cash Position: 9111751.00
ACXP balance_sheet (annual, 2023-12-31) — Capital Stock: 14468.00
ACXP balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 7474188.00
ACXP balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 7474188.00
ACXP balance_sheet (annual, 2023-12-31) — Cash Financial: 7474188.00
ACXP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 8163322.00
ACXP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -9800885.00
ACXP cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 980753.00
ACXP cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 159179.00
ACXP cash_flow (annual, 2023-12-31) — Change In Receivables: -129159.00
ACXP cash_flow (annual, 2023-12-31) — Change In Working Capital: 1010773.00
ACXP cash_flow (annual, 2023-12-31) — Changes In Cash: -1637563.00
ACXP balance_sheet (annual, 2023-12-31) — Common Stock: 14468.00
ACXP balance_sheet (annual, 2023-12-31) — Common Stock Equity: 4666685.00
ACXP cash_flow (annual, 2023-12-31) — Common Stock Issuance: 5944250.00
ACXP balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 2322322.00
ACXP balance_sheet (annual, 2023-12-31) — Current Assets: 7709123.00
ACXP balance_sheet (annual, 2023-12-31) — Current Liabilities: 3042438.00
ACXP income_statement (annual, 2023-12-31) — Diluted Average Shares: 633578.00
ACXP income_statement (annual, 2023-12-31) — Diluted EPS: -23.00
ACXP income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -14577768.00
ACXP income_statement (annual, 2023-12-31) — EBIT: -14577768.00
ACXP income_statement (annual, 2023-12-31) — EBITDA: -14577768.00
ACXP cash_flow (annual, 2023-12-31) — End Cash Position: 7474188.00
ACXP cash_flow (annual, 2023-12-31) — Financing Cash Flow: 8163322.00
ACXP cash_flow (annual, 2023-12-31) — Free Cash Flow: -9800885.00
ACXP income_statement (annual, 2023-12-31) — General And Administrative Expense: 8534171.00
ACXP balance_sheet (annual, 2023-12-31) — Invested Capital: 4666685.00
ACXP cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 5944250.00
ACXP cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 5944250.00
ACXP income_statement (annual, 2023-12-31) — Net Income: -14577768.00
ACXP income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -14577768.00
ACXP income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -14577768.00
ACXP income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -14577768.00
ACXP income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -14577768.00
ACXP cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -14577768.00
ACXP income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -14577768.00
ACXP balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4666685.00
ACXP income_statement (annual, 2023-12-31) — Normalized EBITDA: -14577768.00
ACXP income_statement (annual, 2023-12-31) — Normalized Income: -14577768.00
ACXP cash_flow (annual, 2023-12-31) — Operating Cash Flow: -9800885.00
ACXP income_statement (annual, 2023-12-31) — Operating Income: -14577768.00
ACXP income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
ACXP balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 723411.00
ACXP income_statement (annual, 2023-12-31) — Other Gand A: 8534171.00
ACXP cash_flow (annual, 2023-12-31) — Other Non Cash Items: 559583.00
ACXP balance_sheet (annual, 2023-12-31) — Other Payable: 3809.00
ACXP balance_sheet (annual, 2023-12-31) — Other Receivables: 129159.00
ACXP balance_sheet (annual, 2023-12-31) — Payables: 3809.00
ACXP balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2326131.00
ACXP balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 716307.00
ACXP balance_sheet (annual, 2023-12-31) — Prepaid Assets: 105776.00
ACXP income_statement (annual, 2023-12-31) — Pretax Income: -14577768.00
ACXP cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 2219072.00
ACXP balance_sheet (annual, 2023-12-31) — Receivables: 129159.00
ACXP income_statement (annual, 2023-12-31) — Research And Development: 6043597.00
ACXP balance_sheet (annual, 2023-12-31) — Retained Earnings: -53218853.00
ACXP income_statement (annual, 2023-12-31) — Selling General And Administration: 8534171.00
ACXP balance_sheet (annual, 2023-12-31) — Share Issued: 723411.00
ACXP cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3766110.00
ACXP balance_sheet (annual, 2023-12-31) — Stockholders Equity: 4666685.00
ACXP balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4666685.00
ACXP income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ACXP income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
ACXP balance_sheet (annual, 2023-12-31) — Total Assets: 7709123.00
ACXP balance_sheet (annual, 2023-12-31) — Total Capitalization: 4666685.00
ACXP balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 4666685.00
ACXP income_statement (annual, 2023-12-31) — Total Expenses: 14577768.00
ACXP balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3042438.00
ACXP balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 0.00
ACXP balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ACXP balance_sheet (annual, 2023-12-31) — Total Partnership Capital: -53218853.00
ACXP balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ACXP balance_sheet (annual, 2023-12-31) — Working Capital: 4666685.00
ACXP income_statement (quarterly, 2024-09-30) — Basic Average Shares: 818174.00
ACXP income_statement (quarterly, 2024-09-30) — Basic EPS: -3.45
ACXP income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 818174.00
ACXP income_statement (quarterly, 2024-09-30) — Diluted EPS: -3.45
ACXP income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: -2826598.00
ACXP income_statement (annual, 2024-12-31) — +Operating Expense: 14123227.00
ACXP income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
ACXP balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 67936225.00
ACXP income_statement (annual, 2024-12-31) — Basic Average Shares: 808168.00
ACXP income_statement (annual, 2024-12-31) — Basic EPS: -17.45
ACXP cash_flow (annual, 2024-12-31) — Beginning Cash Position: 7474188.00
ACXP balance_sheet (annual, 2024-12-31) — Capital Stock: 852.00
ACXP balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 3706713.00
ACXP balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3706713.00
ACXP balance_sheet (annual, 2024-12-31) — Cash Financial: 3706713.00
ACXP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 6615956.00
ACXP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -10383431.00
ACXP cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 200404.00
ACXP cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 5653.00
ACXP cash_flow (annual, 2024-12-31) — Change In Receivables: 78032.00
ACXP cash_flow (annual, 2024-12-31) — Change In Working Capital: 284089.00
ACXP cash_flow (annual, 2024-12-31) — Changes In Cash: -3767475.00
ACXP balance_sheet (annual, 2024-12-31) — Common Stock: 852.00
ACXP balance_sheet (annual, 2024-12-31) — Common Stock Equity: 615121.00
ACXP cash_flow (annual, 2024-12-31) — Common Stock Issuance: 6405757.00
ACXP cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
ACXP balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2700425.00
ACXP balance_sheet (annual, 2024-12-31) — Current Assets: 3857963.00
ACXP balance_sheet (annual, 2024-12-31) — Current Liabilities: 3242842.00
ACXP income_statement (annual, 2024-12-31) — Diluted Average Shares: 808168.00
ACXP income_statement (annual, 2024-12-31) — Diluted EPS: -17.45
ACXP income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -14103103.00
ACXP income_statement (annual, 2024-12-31) — EBIT: -14123227.00
ACXP income_statement (annual, 2024-12-31) — EBITDA: -14123227.00
ACXP cash_flow (annual, 2024-12-31) — End Cash Position: 3706713.00
ACXP cash_flow (annual, 2024-12-31) — Financing Cash Flow: 6615956.00
ACXP cash_flow (annual, 2024-12-31) — Free Cash Flow: -10383431.00
ACXP income_statement (annual, 2024-12-31) — General And Administrative Expense: 8719391.00
ACXP income_statement (annual, 2024-12-31) — Interest Income: 20124.00
ACXP income_statement (annual, 2024-12-31) — Interest Income Non Operating: 20124.00
ACXP balance_sheet (annual, 2024-12-31) — Invested Capital: 615121.00
ACXP cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 6405757.00
ACXP cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 6405757.00
ACXP income_statement (annual, 2024-12-31) — Net Income: -14103103.00
ACXP income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -14103103.00
ACXP income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -14103103.00
ACXP income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -14103103.00
ACXP income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -14103103.00
ACXP cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -14103103.00
ACXP income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -14103103.00
ACXP income_statement (annual, 2024-12-31) — Net Interest Income: 20124.00
ACXP income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 20124.00
ACXP balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 615121.00
ACXP income_statement (annual, 2024-12-31) — Normalized EBITDA: -14123227.00
ACXP income_statement (annual, 2024-12-31) — Normalized Income: -14103103.00
ACXP cash_flow (annual, 2024-12-31) — Operating Cash Flow: -10383431.00
ACXP income_statement (annual, 2024-12-31) — Operating Income: -14123227.00
ACXP income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
ACXP balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 851534.00
ACXP income_statement (annual, 2024-12-31) — Other Gand A: 8719391.00
ACXP balance_sheet (annual, 2024-12-31) — Other Payable: 4787.00
ACXP balance_sheet (annual, 2024-12-31) — Other Receivables: 51127.00
ACXP balance_sheet (quarterly, 2024-12-31) — Other Receivables: 51127.00
ACXP balance_sheet (annual, 2024-12-31) — Payables: 4787.00
ACXP balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2705212.00
ACXP balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 537630.00
ACXP balance_sheet (annual, 2024-12-31) — Prepaid Assets: 100123.00
ACXP income_statement (annual, 2024-12-31) — Pretax Income: -14103103.00
ACXP cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 210199.00
ACXP cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
ACXP balance_sheet (annual, 2024-12-31) — Receivables: 51127.00
ACXP cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
ACXP income_statement (annual, 2024-12-31) — Research And Development: 5403836.00
ACXP balance_sheet (annual, 2024-12-31) — Retained Earnings: -67321956.00
ACXP income_statement (annual, 2024-12-31) — Selling General And Administration: 8719391.00
ACXP balance_sheet (annual, 2024-12-31) — Share Issued: 851534.00
ACXP cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3435583.00
ACXP balance_sheet (annual, 2024-12-31) — Stockholders Equity: 615121.00
ACXP balance_sheet (annual, 2024-12-31) — Tangible Book Value: 615121.00
ACXP income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ACXP income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ACXP balance_sheet (annual, 2024-12-31) — Total Assets: 3857963.00
ACXP balance_sheet (annual, 2024-12-31) — Total Capitalization: 615121.00
ACXP balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 615121.00
ACXP income_statement (annual, 2024-12-31) — Total Expenses: 14123227.00
ACXP balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3242842.00
ACXP balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 0.00
ACXP balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ACXP balance_sheet (annual, 2024-12-31) — Working Capital: 615121.00
ACXP income_statement (quarterly, 2025-03-31) — +Operating Expense: 2176484.00
ACXP income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
ACXP balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 71760150.00
ACXP income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1001932.00
ACXP income_statement (quarterly, 2025-03-31) — Basic EPS: -2.15
ACXP cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3706713.00
ACXP balance_sheet (quarterly, 2025-03-31) — Capital Stock: 22398.00
ACXP balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4643887.00
ACXP balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4643887.00
ACXP balance_sheet (quarterly, 2025-03-31) — Cash Financial: 4643887.00
ACXP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 2988673.00
ACXP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2051499.00
ACXP cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -335660.00
ACXP cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -61451.00
ACXP cash_flow (quarterly, 2025-03-31) — Change In Receivables: 51127.00
ACXP cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -345984.00
ACXP cash_flow (quarterly, 2025-03-31) — Changes In Cash: 937174.00
ACXP balance_sheet (quarterly, 2025-03-31) — Common Stock: 22398.00
ACXP balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2311399.00
ACXP cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 2988673.00
ACXP balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2469669.00
ACXP balance_sheet (quarterly, 2025-03-31) — Current Assets: 4805461.00
ACXP balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2494062.00
ACXP income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1001932.00
ACXP income_statement (quarterly, 2025-03-31) — Diluted EPS: -2.15
ACXP income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2149193.00
ACXP income_statement (quarterly, 2025-03-31) — EBIT: -2176484.00
ACXP income_statement (quarterly, 2025-03-31) — EBITDA: -2176484.00
ACXP cash_flow (quarterly, 2025-03-31) — End Cash Position: 4643887.00
ACXP cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 2988673.00
ACXP cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2051499.00
ACXP income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1577686.00
ACXP income_statement (quarterly, 2025-03-31) — Interest Income: 27291.00
ACXP income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 27291.00
ACXP balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2311399.00
ACXP cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 2988673.00
ACXP cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 2988673.00
ACXP income_statement (quarterly, 2025-03-31) — Net Income: -2149193.00
ACXP income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2149193.00
ACXP income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2149193.00
ACXP income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2149193.00
ACXP income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2149193.00
ACXP cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2149193.00
ACXP income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2149193.00